2-Hydroxy-5-phenylazobenzoic acid derivatives and method of treating ulcerative colitis therewith
AssigneeBiorex Laboratories Limited
InventorRosalind P. K. Chan
Life of this patent
Estimating the term…
Loading patent…
AssigneeBiorex Laboratories Limited
InventorRosalind P. K. Chan
Estimating the term…
The present invention provides a pharmaceutical composition for treating ulcerative colitis containing at least one compound of the general formula: ##STR1## wherein X is an --SO.sub.2 -- or --CO-- group and R is either an unsubstituted or substituted non-heterocyclic aromatic ring system or is a radical of the general formula --(CH.sub.2).sub.n --Y, in which Y is a hydroxyl group, an unsubstituted or substituted amino group or a carboxylic or sulphonic acid group and n is a whole number of from 1 to 6 and in which one or more hydrogen atoms in the alkylene radical can be replaced by unsubstituted or substituted amino groups or alkyl radicals and in which the --(CH.sub.2).sub.n --Y radical is either attached directly to the nitrogen atom or via a benzene ring; and/or containing at least one ester thereof and/or at least one non-toxic, pharmaceutically acceptable salt thereof, in admixture with a solid or liquid pharmaceutical diluent or carrier. Furthermore, the present invention provides a process for preparing the compounds of the above-given general formulae and also provides a method of treating ulcerative colitis.
2-Hydroxy-5-phenylazobenzoic acid derivatives of the general formula:
5-(4-Phenylsulphamoylphenylazo)-salicylic acid and the sodium salt thereof.
Disodium salt of 5-(4-carboxymethylcarbamoylphenylazo)-salicylic acid.
5-(Carboxyethylcarbamoyl-4-phenylazo)-salicylic acid and the disodium salt thereof.
5-(Sulphoethylcarbamoyl-4-phenylazo)-salicylic acid.
5-(4-Hydroxyethylcarbamoylphenylazo)-salicylic acid and the sodium salt thereof.
5-(.alpha.-Methylcarboxymethylcarbamoyl-4-phenylazo)-salicylic acid.
5-[(4-Carboxymethylphenyl)-sulphamoyl-4-phenylazo]-salicylic acid.
5-(Carboxypentylcarbamoyl-4-phenylazo)-salicylic acid.
5-(.alpha.-Dimethylaminocarboxypentylcarbamoyl-4-phenylazo)-salicylic acid and the disodium salt thereof.
5-(Diethylaminoethylcarbamoyl-4-phenylazo)-salicylic acid.
A pharmaceutical composition for the treatment of ulcerative colitis in humans, containing an effective amount to treat ulcerative colitis, of at least one compound of the formula:
Dependencies are inferred from the claim text.